share_log

Great Valley Advisor Group Inc. Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Great Valley Advisor Group Inc. Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

大谷顧問集團增持直覺外科公司股份(納斯達克代碼:ISRG)
Defense World ·  2022/09/29 06:22

Great Valley Advisor Group Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 593.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,273 shares of the medical equipment provider's stock after acquiring an additional 4,513 shares during the quarter. Great Valley Advisor Group Inc.'s holdings in Intuitive Surgical were worth $1,058,000 at the end of the most recent reporting period.

據直覺外科公司在提交給美國證券交易委員會的最新Form 13F文件中稱,該公司在第二季度增持了360股份,增持幅度為593.8%。該公司在本季度額外收購了4513股後,擁有這家醫療設備提供商的5273股股票。在最近一次報告期結束時,大谷顧問集團持有的直覺外科公司股份價值1,058,000美元。

A number of other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 28,519,307 shares of the medical equipment provider's stock worth $8,603,704,000 after acquiring an additional 457,262 shares during the period. BlackRock Inc. increased its position in shares of Intuitive Surgical by 0.5% during the first quarter. BlackRock Inc. now owns 26,660,811 shares of the medical equipment provider's stock worth $8,043,033,000 after acquiring an additional 122,151 shares during the period. State Street Corp increased its position in shares of Intuitive Surgical by 2.3% during the first quarter. State Street Corp now owns 15,182,214 shares of the medical equipment provider's stock worth $4,580,170,000 after acquiring an additional 347,468 shares during the period. Capital World Investors increased its holdings in Intuitive Surgical by 0.3% during the first quarter. Capital World Investors now owns 9,687,380 shares of the medical equipment provider's stock valued at $2,922,569,000 after buying an additional 28,839 shares during the period. Finally, Edgewood Management LLC increased its holdings in Intuitive Surgical by 20.3% during the first quarter. Edgewood Management LLC now owns 8,902,682 shares of the medical equipment provider's stock valued at $2,685,761,000 after buying an additional 1,504,353 shares during the period. 82.44% of the stock is owned by hedge funds and other institutional investors.

其他一些機構投資者也調整了對該股的持有量。先鋒集團第一季度增持直覺外科公司股票1.6%。先鋒集團在此期間增持了457,262股,現在擁有28,519,307股這家醫療設備供應商的股票,價值8,603,704,000美元。今年第一季度,貝萊德增持了直覺外科公司的股票,增幅為0.5%。貝萊德股份有限公司在此期間增持了122,151股,目前持有26,660,811股這家醫療設備供應商的股票,價值8,043,033,000美元。道富銀行在第一季度增持了直覺外科公司的股票,增幅為2.3%。道富集團目前持有這家醫療設備提供商15,182,214股票,價值4,580,170,000美元,在此期間額外收購了347,468股票。資本世界投資者在第一季度增持了直覺外科公司0.3%的股份。Capital World Investors現在擁有這家醫療設備提供商的9,687,380股票,價值2,922,569,000美元,在此期間又購買了28,839股票。最後,Edgewood Management LLC在第一季度增持了20.3%的直覺外科公司股份。Edgewood Management LLC現在擁有這家醫療設備提供商8,902,682股股票,價值2,685,761,000美元,在此期間又購買了1,504,353股。82.44%的股票由對衝基金和其他機構投資者持有。

Get
到達
Intuitive Surgical
直覺外科公司
alerts:
警報:

Intuitive Surgical Stock Performance

直覺外科公司股票表現

ISRG opened at $192.40 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $184.94 and a fifty-two week high of $369.69. The company has a fifty day moving average of $217.44 and a two-hundred day moving average of $231.36. The stock has a market capitalization of $68.71 billion, a price-to-earnings ratio of 48.96, a PEG ratio of 5.36 and a beta of 1.31.

ISRG週四開盤報192.40美元。直覺外科公司的股價為184.94美元,為52周低點,52周高點為369.69美元。該公司的50日移動均線切入位在217.44美元,200日移動均線切入位在231.36美元。該股市值687.1億美元,市盈率為48.96倍,市盈率為5.36倍,貝塔係數為1.31。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. The company had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the firm earned $1.42 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current year.
直覺外科公司(納斯達克代碼:ISRG-GET Rating)最近一次發佈收益報告是在7月21日星期四。這家醫療設備供應商公佈本季度每股收益為0.85美元,低於分析師普遍預期的1.04美元(0.19美元)。直覺外科公司的股本回報率為12.04%,淨利潤率為24.05%。該公司當季營收為15.2億美元,高於分析師預期的15.6億美元。去年同期,該公司每股收益為1.42美元。股票研究分析師平均預測,直覺外科公司公司本年度每股收益為3.76歐元。

Insider Buying and Selling at Intuitive Surgical

直覺外科公司的內幕買賣

In other news, Director Amal M. Johnson sold 6,375 shares of the company's stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Gary S. Guthart sold 79,412 shares of the stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the completion of the sale, the chief executive officer now owns 54,607 shares in the company, valued at approximately $11,811,494.10. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of the firm's stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now owns 11,224 shares of the company's stock, valued at approximately $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold 101,162 shares of company stock worth $22,062,916 in the last ninety days. 0.90% of the stock is owned by insiders.

其他新聞方面,董事在8月3日星期三的一筆交易中出售了6,375股該公司股票。這些股票的平均價格為238.04美元,總價值為1,517,505.00美元。交易完成後,董事現在直接擁有該公司11,224股股份,價值約2,671,760.96美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過此超鏈接。在相關新聞中,首席執行官加里·S·古薩特在7月26日星期二的一次交易中出售了79,412股該公司股票。這些股票的平均價格為216.30美元,總成交金額為17,176,815.60美元。出售完成後,首席執行官現在擁有公司54,607股,價值約11,811,494.10美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過美國證券交易委員會網站。此外,在8月3日星期三的一筆交易中,董事出售了6,375股該公司股票。股票以238.04美元的平均價格出售,總成交金額為1,517,505.00美元。出售完成後,董事現在擁有11,224股該公司股票,價值約2,671,760.96美元。關於這次銷售的披露可以找到這裏。在過去的90天裏,內部人士賣出了101,162股公司股票,價值22,062,916美元。該公司0.90%的股份由內部人士持有。

Analysts Set New Price Targets

分析師設定新的價格目標

Several equities analysts recently issued reports on the stock. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a report on Friday, September 9th. Morgan Stanley cut their price objective on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a report on Friday, July 15th. Raymond James cut their price objective on shares of Intuitive Surgical from $294.00 to $255.00 in a report on Friday, July 22nd. The Goldman Sachs Group cut their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating on the stock in a report on Friday, July 29th. Finally, Wells Fargo & Company cut their price objective on shares of Intuitive Surgical to $265.00 in a report on Friday, July 22nd. Six equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $268.00.

幾位股票分析師最近發佈了有關該股的報告。9月9日,Stifel Nicolaus在一份報告中將直覺外科公司股票的目標價從250.00美元上調至260.00美元,並給予該公司“買入”評級。摩根士丹利在7月15日星期五的一份報告中將直覺外科公司的目標股價從300.00美元下調至225.00美元,並對該股設定了“同等權重”的評級。雷蒙德·詹姆斯在7月22日星期五的一份報告中將直覺外科公司的股價目標從294.00美元下調至255.00美元。高盛夫婦在7月29日星期五的一份報告中將直覺外科公司的股票目標價從319.00美元下調至273.00美元,並對該股設定了“買入”評級。最後,富國銀行在7月22日星期五的一份報告中將直覺外科公司的股票目標價下調至265.00美元。6名股票研究分析師對該股的評級為持有,12名分析師對該公司的評級為買入。根據MarketBeat的數據,該股目前的平均評級為“適度買入”,共識目標價為268.00美元。

Intuitive Surgical Profile

直覺外科公司簡介

(Get Rating)

(獲取評級)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直覺外科公司公司開發、製造和營銷產品,使醫生和醫療保健提供者能夠在美國和國際上提高微創護理的質量和獲得微創護理的機會。該公司提供達芬奇外科系統,以實現使用微創方法進行復雜手術;以及離子腔內系統,將其商業產品從外科擴展到能夠進行微創肺活組織檢查的診斷程序。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • A Trio of Q3 Winners With Room to Run
  • This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
  • Can HCA Healthcare Weather the Normalization?
  • Can United Natural Foods Fight Both Inflation and the Fed?
  • Mullen Automotive Is Ready To Get In Gear
  • 免費獲取斯托克新聞網關於直覺外科公司的研究報告
  • 第三季度贏家三人組還有運行的空間
  • 這個小知名的小盤股上漲了139%:這隻股票是買入的嗎?
  • HCA醫療能否經受住正常化的考驗?
  • 聯合天然食品能同時對抗通脹和美聯儲嗎?
  • 馬倫汽車已做好準備投入使用

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直覺外科公司日報》的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對直覺外科公司及相關公司的最新新聞和分析師評級的每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論